Steward Partners Investment Advisory, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1723397
STAMFORD, CT
Position in MDGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$89,133
+$78,141 QoQ
Shares Held
166
+690.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#328
of 411 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Steward Partners Investment Advisory, LLC holds $58,578,486 across 161 Biotechnology names. MDGL ranks #34 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
351,178 | $13,699,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,851 | $10,357,317 | |
| 3 | ARGX |
Argenx SE
|
9,982 | $9,261,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,148 | $3,209,983 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
55,012 | $3,147,786 | |
| 6 | CRMD |
CorMedix Inc.
|
232,615 | $1,826,027 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
165,142 | $1,621,694 | |
| 8 | NKTR |
Nektar Therapeutics
|
18,279 | $1,276,056 |
All Filings in MDGL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,133 | 166 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,992 | 21 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,229 | 21 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,503 | 12 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $302 | 1 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $331 | 1 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||